jksronline.org
eISSN 2951-0805
    J Korean Soc Radiol. 2012 Nov;67(5):349-365. Korean.
    Published online Nov 30, 2012.
    https://doi.org/10.3348/jksr.2012.67.5.349
    Copyright © 2012 The Korean Society of Radiology
    Review

    Korean Society of Thoracic Radiology Guideline for Lung Cancer Screening with Low-Dose CT

    Hyun Ju Lee, MD,1 Jin Hwan Kim, MD,2 Yoon Kyung Kim, MD,3 Chang Min Park, MD,1 Chin A Yi, MD,4 and Yeon Joo Jeong, MD5
      • 1Department of Radiology, Seoul National University Hospital, Seoul, Korea.
      • 2Department of Radiology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.
      • 3Department of Radiology, Gachon University Gil Medical Center, Incheon, Korea.
      • 4Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
      • 5Department of Radiology, Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, Busan, Korea.
    • Corresponding author: Jin-Hwan Kim, MD. Department of Radiology, Chungnam National University Hospital, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 301-721, Korea. Tel. 82-42-280-7838, Fax. 82-42-253-0061, Email: michelan@cnu.ac.kr
    Received August 08, 2012; Accepted October 23, 2012.

    Abstract

    The National Lung Screening Trial (NLST), a nation-wide randomized controlled trial involving more than 50,000 current and former heavy smokers ages 55 to 74, compared the effects of two screening procedures (low-dose helical CT and standard chest radiography) on lung cancer mortality and found 20 percent fewer lung cancer deaths among trial participants screened with low-dose CT. Korean Society of Thoracic Radiology (KSTR) planned to establish an effective guideline for lung cancer screening with low-dose CT to improve health of Korean people and to reduce harms from misuse of lung cancer screening with low-dose CT. KSTR guideline for lung cancer screening with low-dose CT established based on objective medical evidences obtained by NLST.

    Keywords
    Screening; Lung Cancer; Low-Dose CT; Korean Society of Thoracic Radiology; Guideline

    Figures

    Fig. 1
    Estimated New Cancer Cases and Cancer Deaths in the United States (2010).
    A. Estimated New Cancer Cases in the United States. Lung cancer is the second most common cancer in the States being second only to prostate cancer in men and breast cancer in women (from reference 4).

    B. Estimated New Cancer Deaths in the United States (2010). Lung cancer is the leading cause of cancer death in both men (29%) and women (26%). The statistical data shows that lung cancer causes the death of 157300 people every year in the United States (from reference 4).

    Fig. 2
    Age-Standardized Death Rates of Cancers in the Korea (2011). Lung cancer becomes the major causes of cancer death from 1999. Lung cancer causes the largest number of cancer deaths in the Korea, accounts for more deaths than stomach cancer and hepatocellular carcinoma (from reference 5).

    Tables

    Table 1
    KSTR Guideline for Lung Cancer Screening with Low-Dose CT (1)

    Table 2
    KSTR Guideline for Lung Cancer Screening with Low-Dose CT (2)

    Table 3
    Pulmonary Nodule Classification Detected on Screening CT

    Table 4
    Management Protocol according to Nodule Classification

    Table 5
    CT Acquisition Parameters (NLST)

    Table 6
    CT Acquisition Parameters (KSTR)

    Table 7
    Quality Control Tests for CT

    Table 8
    Performance Evaluation of CT Using Phantom

    Table 9
    Quality Control in CT: Clinical Image Quality Assessment

    Table 10
    Radiologic Data Reporting System

    Notes

    This work was supported by the 2012 KSTR Research Grant funded by the Korean Society of Thoracic Radiology.

    References

      1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409.
      1. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418–2429.
      1. NCCN Clinical Practice Guidelines in Oncology. Lung Cancer Screening v1.2013.
        http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
      1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277–300.
      1. Annual Report of the Korea Central Cancer Registry. National Cancer Center Web site.
        http://www.cancer.go.kr/ncic/cics_g/cics_g02/cics_g027/__icsFiles/afieldfile/2011/12/29/111229.pdf.
      1. National Cancer Institute. Non-Small Cell Lung Cancer Treatment (PDQ). Stage 0-4 Non-Small Cell Lung Cancer. 2008 Aug 01;
        http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/HealthProfessional.
      1. Chong S, Lee KS, Chung MJ, Kim TS, Kim H, Kwon OJ, et al. Lung cancer screening with low-dose helical CT in Korea: experiences at the Samsung Medical Center. J Korean Med Sci 2005;20:402–408.
      1. National Lung Screening Trial Research Team. Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, et al. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243–253.
      1. Patz EF Jr, Caporaso NE, Dubinett SM, Massion PP, Hirsch FR, Minna JD, et al. National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers. J Thorac Oncol 2010;5:1502–1506.
      1. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P. Writing Committee, Lung Screening Study Research Group. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest 2004;126:114–121.
      1. Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012;67:296–301.
      1. Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, et al. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round. J Thorac Oncol 2009;4:608–614.
      1. Sun PL, Seol H, Lee HJ, Yoo SB, Kim H, Xu X, et al. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features. J Thorac Oncol 2012;7:323–330.
      1. Jang TW, Kim YC, Kwon YS, Oh IJ, Kim KS, Kim SY, et al. Female lung cancer: re-analysis of national survey of lung cancer in Korea, 2005. J Lung Cancer 2010;9:57–63.
      1. Patel JD. Lung cancer in women. J Clin Oncol 2005;23:3212–3218.
      1. Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Takashima S, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001;84:25–32.
      1. Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004;231:440–445.
      1. Berrington de González A, Kim KP, Berg CD. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen 2008;15:153–158.
      1. Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC. American College of Chest Physicians. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132 3 Suppl:94S–107S.
      1. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221–2229.
      1. Midthun DE, Swensen SJ, Jett JR, Hartman TE. Evaluation of nodules detected by screening for lung cancer with low dose spiral computed tomography. Lung Cancer 2003;41:S40.
      1. Henschke CI, Yankelevitz DF, Naidich DP, McCauley DI, McGuinness G, Libby DM, et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004;231:164–168.
      1. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS. ELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002;178:1053–1057.
      1. Lopes Pegna A, Picozzi G, Mascalchi M, Maria Carozzi F, Carrozzi L, Comin C, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009;64:34–40.
      1. Aberle DR, Gamsu G, Henschke CI, Naidich DP, Swensen SJ. A consensus statement of the Society of Thoracic Radiology: screening for lung cancer with helical computed tomography. J Thorac Imaging 2001;16:65–68.
      1. Xu DM, Gietema H, de Koning H, Vernhout R, Nackaerts K, Prokop M, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177–184.
      1. Ministry of Health and Welfare. Act No.65.
        [Enforcement Date 27. Jun, 2011].
    Cited by
    Crossref 8
    Google Scholar 
    MeSH Terms
    Lung
    Lung Neoplasms
    Mass Screening
    Thorax
    Tomography, Spiral Computed
    Metrics
    Share
    Figures
    slide
    slide

    1 / 2

    Tables
    slide
    slide
    slide
    slide
    slide
    slide
    slide
    slide
    slide
    slide

    1 / 10

    Funding Information
    PERMALINK